Rothschild & Co Asset Management US’s Medpace MEDP Stock Holding History

Rothschild & Co Asset Management US’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$5.81M	Sell	27,353 -4,220	-13%	-$843K	0.09%	166
2022 Q3	$4.96M	Buy	31,573 +614	+2%	+$98K	0.08%	176
2022 Q2	$4.63M	Sell	30,959 -1,017	-3%	-$147K	0.07%	187
2022 Q1	$5.23M	Sell	31,976 -11,725	-27%	-$1.93M	0.07%	198
2021 Q4	$9.51M	Sell	43,701 -2,900	-6%	-$607K	0.11%	181
2021 Q3	$8.82M	Sell	46,601 -7,290	-14%	-$1.33M	0.11%	187
2021 Q2	$9.52M	Sell	53,891 -1,868	-3%	-$322K	0.11%	189
2021 Q1	$9.15M	Sell	55,759 -7,172	-11%	-$1.1M	0.11%	198
2020 Q4	$8.76M	Buy	+62,931	New	+$7.93M	0.11%	200

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Rothschild & Co Asset Management US's MEDP Position: Q4 2022 in Review

Rothschild & Co Asset Management US reduced its Medpace (MEDP) stake by 13% in Q4 2022, selling an estimated $843K and leaving 27,353 shares worth $5.81M. The position accounts for 0.09% of the portfolio, ranked #166.

Rothschild & Co Asset Management US first reported a position in MEDP in Q4 2020 and has held it in 9 quarters since. The position peaked at $9.52M in Q2 2021. 422 funds tracked by Wall St. Rank hold MEDP as of Q4 2022.

Rothschild & Co Asset Management US held 27,353 shares of Medpace worth $5.81M as of Q4 2022.
Rothschild & Co Asset Management US sold 4,220 Medpace shares in Q4 2022, an estimated $843K.
Medpace made up 0.09% of Rothschild & Co Asset Management US's portfolio in Q4 2022, its #166 holding.
Rothschild & Co Asset Management US first reported a position in Medpace in Q4 2020 and has held it in 9 quarters since.
Rothschild & Co Asset Management US's Medpace position peaked at $9.52M in Q2 2021.
422 funds tracked by Wall St. Rank held Medpace as of Q4 2022.

Based on Rothschild & Co Asset Management US's 13F filing for Q4 2022, filed 14 Feb 2023.